This is consistent with our previous observation that aromatase inhibition is likely to mediate increased insulin resistance through reduced peripheral glucose disposal in skeletal muscle (12) (captured by the dynamic insulin sensitivity index but not the static HOMA-IR). The gene discussed is CYP19A1; the disease is Insulin resistance.